ConductScience.org, home

Paper7902829

Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.

Pinski J and 3 others. Int J Cancer, 1993. Cited by 71 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Papers, record 7902829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7902829

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
PubMed
Journal
Int J Cancer
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2019-07-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pinski JJ
2Schally AVA V
3Halmos GG
4Szepeshazi KK

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
BombesinMajor topic
CarcinomaMajor topic
Peptide FragmentsMajor topic
Prostatic NeoplasmsMajor topic
SomatostatinMajor topic
Animals
Cell Division
ErbB Receptors
Male
Mice
Mice, Nude
Neoplasm Transplantation
Organ Size
Receptors, Bombesin
Receptors, Somatostatin
Transplantation, Heterologous
Tumor Cells, Cultured

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA 40003NCI NIH HHSUnited StatesR01CA040003PubMed and NIH

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
39,768,218GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma.Cells2024https://conductscience.org/library/papers/39768218PubMed
38,540,191The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review.Biomedicines2024https://conductscience.org/library/papers/38540191PubMed
38,203,605Somatostatin and Somatostatin Receptors in Tumour Biology.Int J Mol Sci2023https://conductscience.org/library/papers/38203605PubMed
36,077,458PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.Int J Mol Sci2022https://conductscience.org/library/papers/36077458PubMed
34,810,259Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34810259PubMed
20,182,713A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.Eur J Nucl Med Mol Imaging2010https://conductscience.org/library/papers/20182713PubMed
9,465,096Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9465096PubMed
9,380,734A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9380734PubMed
9,366,567Constitutive activation of the gastrin-releasing peptide receptor expressed by the nonmalignant human colon epithelial cell line NCM460.J Clin Invest1997https://conductscience.org/library/papers/9366567PubMed
7,740,652Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.Urol Res1995https://conductscience.org/library/papers/7740652PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGF1,950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
GAST2,520PubTator's text mininghttps://conductscience.org/library/genes/2520NCBI Gene
GH12,688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
GRP2,922PubTator's text mininghttps://conductscience.org/library/genes/2922NCBI Gene
SST6,750PubTator's text mininghttps://conductscience.org/library/genes/6750NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7902829

GET https://conductscience.org/api/papers/v1/7902829/authors